AMYLOIDOSIS
Clinical trials for AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chemo formula may reduce side effects in blood cancer patients
Disease control OngoingThis study tests a new version of the chemotherapy drug melphalan (called Captisol Enabled Melphalan) in people with multiple myeloma or AL amyloidosis who are getting a stem cell transplant. The new formulation is designed to be more stable and possibly cause fewer side effects …
Matched conditions: AMYLOIDOSIS
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:50 UTC
-
New hope for rare heart disease: drug combo targets amyloid buildup
Disease control OngoingThis study tests a drug combination (daratumumab plus chemotherapy) in people newly diagnosed with AL amyloidosis, a rare condition where abnormal proteins damage organs, especially the heart. The main goals are to check heart safety and to see how the drug works in different rac…
Matched conditions: AMYLOIDOSIS
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 19, 2026 11:47 UTC